Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations

Overview of attention for article published in Journal for Immunotherapy of Cancer, December 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

So far, Dimensions has found 202 publications that cite this research output.

Article in Cancer Treatment Reviews (September 2023)

Article in Pharmaceutics (August 2023)

Article in Kompass Onkologie (August 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.